Device
CARTO
CARTO is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed133%
withdrawn133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completed
RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation
NCT04835844
withdrawnnot_applicable
Comparison of Carto Versus Ensite 3D Electroanatomical Mapping Systems for Arrhythmias Ablations
NCT01651702
unknownnot_applicable
Catheter Ablation of Longstanding Persistent Atrial Fibrillation
NCT02929836
Clinical Trials (3)
Showing 3 of 3 trials
NCT04835844
RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation
NCT01651702Not Applicable
Comparison of Carto Versus Ensite 3D Electroanatomical Mapping Systems for Arrhythmias Ablations
NCT02929836Not Applicable
Catheter Ablation of Longstanding Persistent Atrial Fibrillation
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3